This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Land, A. M.
Right arrow Articles by Plummer, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Land, A. M.
Right arrow Articles by Plummer, F. A.

 Previous Article  |  Next Article 

Journal of Virology, August 2008, p. 8172-8182, Vol. 82, No. 16
0022-538X/08/$08.00+0     doi:10.1128/JVI.01115-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya{triangledown}

Allison M. Land,1 T. Blake Ball,1* Ma Luo,1 Richard Pilon,2 Paul Sandstrom,2 Joanne E. Embree,1 Charles Wachihi,3 Joshua Kimani,3 and Francis A. Plummer1,4

Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada,1 National HIV and Retrovirology Laboratories, Public Health Agency of Canada, Ottawa, Ontario, Canada,2 Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya,3 Public Health Agency of Canada, Winnipeg, Manitoba, Canada4

Received 27 May 2008/ Accepted 4 June 2008

APOBEC3G is an important innate immune molecule that causes human immunodeficiency virus type 1 (HIV-1) hypermutation, which can result in detrimental viral genome mutations. The Vif protein of wild-type HIV-1 counteracts APOBEC3G activity by targeting it for degradation and inhibiting its incorporation into viral particles. Additional APOBEC cytidine deaminases have been identified, such as APOBEC3F, which has a similar mode of action but different sequence specificity. A relationship between APOBEC3F/G and HIV disease progression has been proposed. During HIV-1 sequence analysis of the vpu/env region of 240 HIV-infected subjects from Nairobi, Kenya, 13 drastically hypermutated proviral sequences were identified. Sequences derived from plasma virus, however, lacked hypermutation, as did proviral vif. When correlates of disease progression were examined, subjects with hypermutated provirus were found to have significantly higher CD4 counts than the other subjects. Furthermore, hypermutation as estimated by elevated adenine content positively correlated with CD4 count for all 240 study subjects. The sequence context of the observed hypermutation was statistically associated with APOBEC3F/G activity. In contrast to previous studies, this study demonstrates that higher CD4 counts correlate with increased hypermutation in the absence of obvious mutations in the APOBEC inhibiting Vif protein. This strongly suggests that host factors, such as APOBEC3F/G, are playing a protective role in these patients, modulating viral hypermutation and host disease progression. These findings support the potential of targeting APOBEC3F/G for therapeutic purposes.

* Corresponding author. Mailing address: Department of Medical Microbiology, University of Manitoba, Basic Medical Sciences Building, Room 507, 730 William Avenue, Winnipeg, Manitoba R3E 0W3, Canada. Phone: (204) 789-3202. Fax: (204) 789-3926. E-mail: tball{at}cc.umanitoba.ca

{triangledown} Published ahead of print on 11 June 2008.

Journal of Virology, August 2008, p. 8172-8182, Vol. 82, No. 16
0022-538X/08/$08.00+0     doi:10.1128/JVI.01115-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Abrahams, M.-R., Anderson, J. A., Giorgi, E. E., Seoighe, C., Mlisana, K., Ping, L.-H., Athreya, G. S., Treurnicht, F. K., Keele, B. F., Wood, N., Salazar-Gonzalez, J. F., Bhattacharya, T., Chu, H., Hoffman, I., Galvin, S., Mapanje, C., Kazembe, P., Thebus, R., Fiscus, S., Hide, W., Cohen, M. S., Karim, S. A., Haynes, B. F., Shaw, G. M., Hahn, B. H., Korber, B. T., Swanstrom, R., Williamson, C., for the CAPRISA Acute Infection Study Team and the, (2009). Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants. J. Virol. 83: 3556-3567 [Abstract] [Full Text]  
  • Malim, M. H (2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Phil Trans R Soc B 364: 675-687 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»